QUOTE
AVI BioPharma, Inc. (AVII)
$
0.91
 -0.01 (-1.09%) Jan 26
|
One S.W. Columbia Street Suite 1105
,
Portland,
OR
97258
,
USA
+1-503-227-0554
http://www.antivirals.com/ |
|
|
| PRICES |
| Open |
Volume |
| 0.94 |
474,100 |
| High |
Low |
| 0.95 |
0.88 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| 101 |
229,600 |
| 52wk High |
52wk Low |
| 2.17 |
0.54 |
|
| RATIOS |
| P/E |
EPS |
| n/a |
n/a |
| BV |
P/BV |
| 0.04 |
22.75 |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| n/a |
n/a |
| Shares |
Inst Owner |
| 110.50 |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of USD)
|
| |
2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 |
| Income statement |
| Total Revenue |
$0.97 | $0.43 | $4.78 | $0.12 | $10.98 | $21.26 | $17.59 |
| Operating Income |
$-18.87 | $-25.05 | $-17.52 | $-32.98 | $-33.11 | $-27.46 | $-15.51 |
| Net Income |
$-14.62 | $-24.78 | $-16.68 | $-31.07 | $-27.17 | $-23.95 | $-25.16 |
| Balance Sheet |
| Total Assets |
$47.14 | $28.52 | $56.41 | $40.86 | $38.64 | $25.54 | $60.03 |
| Total Equity |
$43.39 | $26.27 | $53.66 | $37.71 | $26.38 | $15.73 | $23.63 |
| Total Liabilities |
$3.75 | $2.25 | $2.75 | $3.15 | $12.26 | $9.80 | $36.40 |
| Cash Flow |
| Operating |
$-17.48 | $-23.78 | $-14.67 | $-20.61 | $-24.68 | $-12.34 | $-8.80 |
| Investing |
$-15.46 | $20.84 | $-10.92 | $-1.99 | $10.58 | $-1.24 | $-1.88 |
| Financing |
$35.08 | $7.07 | $43.53 | $8.16 | $18.75 | $-0.03 | $47.77 |
| Net Cash Change |
$2.14 | $4.13 | $17.94 | $-14.44 | $4.64 | $-13.61 | $37.08 |
|
Earning Call Calender
|
| 2010 | 2009 |
2008 |
2007 |
2006 |
16 March 2010
10 May 2010
09 August 2010
09 November 2010
|
10 March 2009
11 May 2009
10 August 2009
09 November 2009
|
12 March 2008
12 May 2008
11 August 2008
10 November 2008
|
15 March 2007
09 May 2007
08 August 2007
06 November 2007
|
| |
|
| Earning Call Summary |
Transcripts |
| |
|
Management
|
|
Executive |
Title |
|
Michael D. Casey |
Chairman of the Board | |
|
Leslie Hudson |
Chief Executive Officer, Director |
|
K. Michael Forrest |
Director |
|
Alan P. Timmins |
President, Chief Operating Officer, Director |
|
Mark M. Webber |
Chief Financial Officer, Chief Information Officer |
|
Patrick L. Iversen |
Senior Vice President of Strategic Alliances |
|
Peter D. OHanley |
Senior Vice President - Clinical Development and Regulatory Affiars |
|
Dwight D. Weller |
Senior Vice President - Chemistry and Manufacturing |
|
|
|
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites. Market data: BATS Exchange. Inc
